8-K: LENSAR, Inc. Grants Stock Units to Key Executives

LENSAR, Inc. has granted restricted stock units (RSUs) and performance stock units (PSUs) to three key executives, with PSU vesting tied to revenue targets.

Summary

• LENSAR, Inc.'s board of directors approved the grant of restricted stock units (RSUs) and performance stock units (PSUs) to Nicholas T. Curtis, Alan B. Connaughton, and Thomas R. Staab, II.
• The RSUs were granted on May 6, 2024, and will vest in four equal annual installments.
• The PSUs were also granted on May 6, 2024, and will vest based on the company's revenue performance.
• 50% of the PSUs will vest if the company's cumulative one-year trailing revenues reach or exceed $75 million by the end of any calendar quarter before December 31, 2026.
• The remaining 50% of the PSUs will vest if the company's cumulative one-year trailing revenues reach or exceed $100 million by the end of any calendar quarter before December 31, 2027.
• Nicholas T. Curtis received 71,400 RSUs and 71,400 PSUs.
• Alan B. Connaughton received 45,000 RSUs and 45,000 PSUs.
• Thomas R. Staab, II received 19,000 RSUs and 19,000 PSUs.

Sentiment

Score: 7

Explanation: The document outlines a standard executive compensation plan with performance-based incentives, which is generally viewed positively. The sentiment is neutral to slightly positive as it aligns management with shareholder interests.

Positives

• The incentive plan aligns executive compensation with company performance, specifically revenue growth.
• The vesting schedule for RSUs provides a retention incentive for the executives.
• The performance-based vesting of PSUs encourages executives to drive revenue growth.

Risks

• The company may not achieve the revenue targets required for the PSUs to vest.
• The value of the stock units is subject to market fluctuations.

Future Outlook

The company's future performance, particularly revenue growth, will determine the vesting of the performance stock units.

Industry Context

The use of stock-based compensation is a common practice in the technology and medical device industries to incentivize executives and align their interests with those of shareholders.

Comparison to Industry Standards

• Stock-based compensation is a standard practice in the medical device industry, with companies like Alcon and Johnson & Johnson also using similar incentive structures.
• The revenue targets for PSU vesting are specific to LENSAR's growth trajectory and are not directly comparable to other companies without detailed financial analysis.
• The vesting schedules for RSUs are fairly standard, with many companies using a four-year vesting period.

Stakeholder Impact

• Shareholders may view the incentive plan positively as it aligns executive interests with company performance.
• Employees may be motivated by the potential for company growth and success.
• The vesting of PSUs is contingent on the company achieving revenue targets, which could impact the company's financial performance.

Next Steps

• The company will need to monitor its revenue performance against the targets set for PSU vesting.
• The executives will need to meet the vesting requirements to realize the full value of their stock units.

Key Dates

Keywords

stock units, RSU, PSU, executive compensation, revenue targets, incentive plan, vesting, LENSAR